Carlos Moreira
Clinical Research Coordinator
Medicine
School of Medicine

I initiated my medical career within the Brazilian public health system, serving marginalized and diverse populations. This journey included providing essential healthcare in the Amazon Rainforest, where I catered to the unique needs of indigenous tribes and isolated communities. In São Paulo, my roles were diverse, encompassing positions as an Infectious Diseases consultant, General Practitioner, and Emergency Room leader. These experiences have sharpened my adaptability, critical thinking, and public health leadership skills.

I am currently continuing my commitment to patient care. I am a member of the 2027 Family Medicine Residency Class at Sutter’s Santa Rosa. My research interests are extensive and committed to evidence-based medicine, including an NIH-funded study on overcoming treatment barriers for Chagas Disease in Brazil and investigating the impacts of COVID-19 on vulnerable populations. My ultimate aim is to transform practical challenges into impactful research that fosters systemic changes in healthcare and delivers better care to our patients.

• Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
  International journal of molecular sciences 2021 Franco LAM, Moreira CHV, Buss LF, Oliveira LC, Martins RCR, Manuli ER, Lindoso JAL, Busch MP, Pereira AC, Sabino EC
• Galectin-3 Associated with Severe Forms and Long-term Mortality in Patients with Chagas Disease.
  Arquivos brasileiros de cardiologia 2021 Fernandes F, Moreira CHV, Oliveira LC, Souza-Basqueira M, Ianni BM, Lorenzo CD, Ramires FJA, Nastari L, Cunha-Neto E, Ribeiro AL, Lopes RD, Keating SM, Sabino EC, Mady C
• Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors.
  PLoS neglected tropical diseases 2020 Buss LF, Campos de Oliveira-da Silva L, Moreira CHV, Manuli ER, Sales FC, Morales I, Di Germanio C, de Almeida-Neto C, Bakkour S, Constable P, Pinto-Filho MM, Ribeiro AL, Busch M, Sabino EC
• Viral gastroenteritis in Tocantins, Brazil: characterizing the diversity of human adenovirus F through next-generation sequencing and bioinformatics.
  The Journal of general virology 2020 Tahmasebi R, Luchs A, Tardy K, Hefford PM, Tinker RJ, Eilami O, de Padua Milagres FA, Brustulin R, Teles MDAR, Dos Santos Morais V, Moreira CHV, Buccheri R, Araújo ELL, Villanova F, Deng X, Sabino EC,…
• Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis.
  Frontiers in cellular and infection microbiology 2020 de Souza-Basqueira M, Ribeiro RM, de Oliveira LC, Moreira CHV, Martins RCR, Franco DC, Amado PPP, Mayer MPA, Sabino EC
• Galectin-3 Levels in Patients with Chronic Constrictive Pericarditis.
  Arquivos brasileiros de cardiologia 2020 Fernandes F, Melo DTP, Ramires FJA, Sabino EC, Moreira CHV, Benvenutti LA, Hotta VT, Sayegh ALC, Souza FR, Dias RR, Mady C
• ELISA Saliva for Trypanosoma cruzi Antibody Detection: An Alternative for Serological Surveys in Endemic Regions.
  The American journal of tropical medicine and hygiene 2020 de Oliveira LC, Pereira NB, Moreira CHV, Bierrenbach AL, Salles FC, de Souza-Basqueira M, Manuli ER, Ferreira AM, Oliveira CDL, Cardoso CS, Ribeiro ALP, Sabino EC
• Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.
  Journal of the American Heart Association 2020 Di Lorenzo Oliveira C, Nunes MCP, Colosimo EA, de Lima EM, Cardoso CS, Ferreira AM, de Oliveira LC, Moreira CHV, Bierrenbach AL, Haikal DSA, Peixoto SV, Lima-Costa MF, Sabino EC, Ribeiro ALP
• Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study).
  BMJ open 2019 Figueiredo-Mello C, Casadio LVB, Avelino-Silva VI, Yeh-Li H, Sztajnbok J, Joelsons D, Antonio MB, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Salles APM, Corá AP, Moreira CHV, Ribeiro AF, Nastri ACSS, …
• Social and behavioral characteristics of male blood donors and their sexual partners: an analysis to define risk subsets.
  Transfusion 2019 Salomon T, Gomes I, Ozahata MC, Moreira CHV, Oliveira CDL, Gonçalez TT, Duarte ME, Miranda C, Carneiro Proietti AB, Sabino E, de Almeida Neto C, Custer B, NHLBI Retrovirus Epidemiology Donor Study-II…
• Predictors of mortality in patients with yellow fever: an observational cohort study.
  The Lancet. Infectious diseases 2019 Kallas EG, D'Elia Zanella LGFAB, Moreira CHV, Buccheri R, Diniz GBF, Castiñeiras ACP, Costa PR, Dias JZC, Marmorato MP, Song ATW, Maestri A, Borges IC, Joelsons D, Cerqueira NB, Santiago E Souza NC, …
• Lack of evidence of seronegative infection in an endemic area of Chagas disease.
  Revista do Instituto de Medicina Tropical de Sao Paulo 2019 Oliveira LC, Lee TH, Ferreira AM, Bierrenbach AL, Souza-Basqueira M, Oliveira CDL, Cardoso CS, Moreira CHV, Oikawa MK, Ribeiro ALP, Busch MP, Sabino EC
• Visceral leishmaniasis and HIV coinfection: current perspectives.
  HIV/AIDS (Auckland, N.Z.) 2018 Lindoso JAL, Moreira CHV, Cunha MA, Queiroz IT
• Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
  Revista da Sociedade Brasileira de Medicina Tropical 2018 Lindoso JAL, Moreira CHV, Celeste BJ, Oyafuso LKM, Folegatti PM, Zijlstra EE
• Importance of Clinical and Laboratory Findings in the Diagnosis and Surgical Prognosis of Patients with Constrictive Pericarditis.
  Arquivos brasileiros de cardiologia 2017 Fernandes F, Melo DTP, Ramires FJA, Dias RR, Tonini M, Fernandes VDS, Rochitte CE, Moreira CHV, Mady C
• Leishmaniasis-HIV coinfection: current challenges.
  HIV/AIDS (Auckland, N.Z.) 2016 Lindoso JA, Cunha MA, Queiroz IT, Moreira CH